bluebird bio
Data Breaches, Cyber Attacks and Security Report

https://bluebirdbio.com  ᛫  Biotech & Pharmaceuticals
Last updated November 12, 2019

About bluebird bio

Company Overview

bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. Our objective is to develop and bring to market the most advanced products based on the transformative potential of gene therapy to provide patients hope for a better life in the face of limited or no long-term safe and effective treatment options. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.

Valuation

Employees

CEO

Nick Leschly

Location

Data Breaches and Security News

bluebird bio Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely bluebird bio is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for bluebird bio

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare bluebird bio's security performance with other companies